TISSIUM

Biotech · Paris, FR · tissium.com

Medtech developing biomorphic programmable polymers for tissue reconstruction

Founders

Christophe Bancel (France · ♂) — A biotech executive and serial co-founder, he partnered with MIT-trained inventor Maria Pereira to found TISSIUM (originally Gecko Biomedical) in 2013 to commercialize programmable polymers for tissue repair, serving as CEO.
Maria Pereira (Portugal · ♀) — She invented the biomorphic adhesive polymer during her PhD work in the MIT labs of Bob Langer and Jeff Karp, and co-founded TISSIUM in 2013 to bring sutureless tissue reconstruction to surgery.

Shares the most investors with (number = shared investors):

Date	Round	Amount
May 2023	Funding round French medtech Tissium received an investment from the Fonds Stratégique des Transitions.	—
May 2023	Series D Plus TISSIUM closed a EUR50M Series D from investors including ISALT, Merieux Developpement, Cathay Health, Credit Mutuel Innovation and Sofinnova Partners.	$54M
Aug 2021	Series C Paris medtech Tissium raised a EUR 50M Series C led by Cathay Health to commercialise its tissue-reconstruction polymers.	$59M

Tap an investor to see what else they have backed.

Data is community-curated and may be incomplete.